Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults =75 years (EU-COVAT-1-AGED)-final report
Por:
Stemler, J, Yeghiazaryan, L, Stephan, C, Mohn, KG, Cox, RJ, Carcas-Sansuan, AJ, Rodriguez, ER, Moltó, J, Mitxeltorena, IV, Pink, I, Welte, T, Zablockiene, B, Akova, M, Bethe, U, Grimm, S, Salmanton-Garcia, J, Jakobs, J, Tischmann, L, Zarrouk, M, Cüppers, A, Biehl, LM, Grothe, J, Mellinghoff, SC, Nacov, JA, Neuhann, JM, Sprute, R, Frias-Iniesta, J, Negi, R, Gaillard, C, Saini, G, León, AG, Mallon, PWG, Lammens, C, Hotterbeekx, A, Loens, K, Malhotra-Kumar, S, Goossens, H, Kumar-Singh, S, König, F, Posch, M, Koehler, P and Cornely, OA
Publicada:
1 abr 2026
Resumen:
Background: To determine long-term immunogenicity and reactogenicity of different SARS-CoV-2 messenger RNA (mRNA) vaccines in a population >= 75 years of age in a randomized trial. Methods: Participants were randomized to receive either BNT162b2 30 & micro;g or a double booster dose of mRNA-1273, i.e., 100 & micro;g, as the third and fourth vaccinations (first and second booster). The primary endpoint was the rate of a two-fold geometric mean titer (GMT) antibody increase 14 days after vaccination targeting the receptor binding domain (RBD) region of wild-type SARS-CoV-2. Secondary endpoints included neutralizing capacity against wild-type and 25 variants at 14 days (D14) and 12 months (M12). Safety was assessed by monitoring adverse events (AEs) for 7 days after vaccination. Findings: Between November 2021 and September 2022, 322 participants received a SARS-CoV-2 vaccine as a first (Part A) or second booster (Part B). Primary endpoint results have been published previously. In Part A, it was reached by 100% of participants in both vaccine arms, with a higher GMT increase in the mRNA-1273 arm (ratio, 1.64). At M12, the GMT of anti-RBD immunoglobulin G (IgG) was slightly higher than at D14 (9319.7 vs 8568.4 IU/mL) in the BNT162b2 arm, while in the mRNA-1273 arm, the GMT was equal (14,163.8 vs 14,266.7 IU/mL at D14). In Part B, the primary endpoint was reached by 78.5% of participants in the BNT162b2 and 87.2% in the mRNA-1273 arm (P = 0.056), respectively, with a higher GMT increase of anti-RBD IgG for mRNA-1273 (ratio, 1.38). At M12, GMT of anti-RBD IgG was markedly lower than at D14 (9962 vs 15,248.2 IU/mL) in the BNT162b2 arm as well as in the mRNA-1273 arm (12,024.3 vs 21,325.6 IU/mL). Higher neutralizing capacity in individuals who received a booster with mRNA-1273 was detected against wild-type and 15 of 25 tested variants. Fewer participants in the mRNA-1273 arm had vaccine-related AEs (29.6% vs 38.5%), but severity was more frequently grade 2 (n = 38, 28.1% vs n = 22, 16.3%). Interpretation: Long-term serological immunogenicity and virus neutralization capacity in participants >= 75 years of age were numerically better with an mRNA-1273 100 & micro;g booster, with a comparable safety profile. (c) 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Filiaciones:
Stemler, J:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Yeghiazaryan, L:
Med Univ Vienna, Inst Med Stat, Ctr Med Data Sci, Vienna, Austria
Stephan, C:
Univ Hosp Frankfurt, Dept Internal Med, Infect Dis, Frankfurt, Germany
Mohn, KG:
Haukeland Hosp, Dept Microbiol, Helse Bergen HF, Bergen, Norway
Univ Bergen, Influenza Ctr, Dept Clin Sci, Bergen, Norway
Cox, RJ:
Haukeland Hosp, Dept Microbiol, Helse Bergen HF, Bergen, Norway
Univ Bergen, Influenza Ctr, Dept Clin Sci, Bergen, Norway
Carcas-Sansuan, AJ:
Univ Autonoma Madrid, Inst Hlth Res IdiPAZ, Fac Med, Clin Pharmacol Serv,Hosp Univ La Paz, Madrid, Spain
Rodriguez, ER:
Dist Sanitario Cordoba Guadalquivir, Primary Care Unit, Isla Lanzarote s-n, Cordoba, Spain
Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
:
Hosp Univ Germans, Dept Infect Dis, Fundacio Lluita Infecc, Barcelona, Spain
Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERInfec, Madrid, Spain
Mitxeltorena, IV:
Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERInfec, Madrid, Spain
Gipuzkoa Integrated Hlth Org, Asociac Inst BIODONOSTIA, Primary Care Res Unit, San Sebastian, Gipuzkoa, Spain
Pink, I:
Hannover Med Sch, Dept Resp Med & Infect Dis, Hannover, Germany
Welte, T:
Hannover Med Sch, Dept Resp Med & Infect Dis, Hannover, Germany
Zablockiene, B:
Vilnius Univ Hosp, Ctr Infect Dis, Santaros Klin, Vilnius, Lithuania
Vilnius Univ, Fac Med, Inst Clin Med, Clin Infect Dis Dermatovenerol, Vilnius, Lithuania
Akova, M:
Hacettepe Univ, Sch Med, Dept Infect Dis, Ankara, Turkiye
Bethe, U:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Grimm, S:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Salmanton-Garcia, J:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Jakobs, J:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Tischmann, L:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Zarrouk, M:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Cüppers, A:
Univ Cologne, Fac Med, Clin Trials Ctr Cologne CTCC Cologne, Cologne, Germany
Biehl, LM:
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Fraunhofer Inst Translat Med & Pharmacol ITMP, Frankfurt, Germany
Fraunhofer Cluster Excellence Immune Mediated Dis, Frankfurt, Germany
Grothe, J:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Mellinghoff, SC:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Nacov, JA:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Neuhann, JM:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Sprute, R:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Frias-Iniesta, J:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Negi, R:
Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Sch Med, Belfield, Ireland
Gaillard, C:
Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Sch Med, Belfield, Ireland
Saini, G:
Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Sch Med, Belfield, Ireland
León, AG:
Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Sch Med, Belfield, Ireland
Mallon, PWG:
Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Sch Med, Belfield, Ireland
Lammens, C:
Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Antwerp, Belgium
Univ Antwerp, Biobank Antwerp, Antwerp, Belgium
Hotterbeekx, A:
Univ Antwerp, Mol Pathol Grp, Fac Med, Lab Cell Biol & Histol CBH, Antwerp, Belgium
Univ Antwerp, Vaccine & Infect Dis Inst CBH, Fac Med, Antwerp, Belgium
Loens, K:
Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Antwerp, Belgium
Univ Antwerp, Biobank Antwerp, Antwerp, Belgium
Malhotra-Kumar, S:
Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Antwerp, Belgium
Univ Antwerp, Biobank Antwerp, Antwerp, Belgium
Goossens, H:
Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Antwerp, Belgium
Univ Antwerp, Biobank Antwerp, Antwerp, Belgium
Kumar-Singh, S:
Univ Antwerp, Mol Pathol Grp, Fac Med, Lab Cell Biol & Histol CBH, Antwerp, Belgium
Univ Antwerp, Vaccine & Infect Dis Inst CBH, Fac Med, Antwerp, Belgium
König, F:
Med Univ Vienna, Inst Med Stat, Ctr Med Data Sci, Vienna, Austria
Posch, M:
Med Univ Vienna, Inst Med Stat, Ctr Med Data Sci, Vienna, Austria
Koehler, P:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Cologne, Germany
Univ Hosp Cologne, Dept Internal Med 1, Div Clin Immunol, Cologne, Germany
Cornely, OA:
Univ Cologne, Inst Translat Res, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Univ Cologne, Fac Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
Univ Hosp Cologne, Cologne, Germany
German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany
Univ Cologne, Fac Med, Clin Trials Ctr Cologne CTCC Cologne, Cologne, Germany
gold
|